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AbstrAct
Hydrogen sulfide is the “third” gasotransmitter on the rise in cardiovascular research. Recent studies 
show that hydrogen sulfide has a great potential in the regulation of vascular tone of systemic arteries and 
many molecular targets are discussed. However, the complex mechanism of vascular tone regulation by 
hydrogen sulfide is only incompletely understood. It seems that a potent interaction of hydrogen sulfide with 
vascular endothelial growth factor (VEGF) becomes important in angiogenesis, in the process of wound 
healing, but also in tumor angiogenesis. Hydrogen sulfide exerts anti-inflammatory effects and it could be a 
pharmacological target in vascular dysfunction in association with obesity-related hypertension as well as in 
tumor development and progression. However, the underlying molecular pathways still need to be revealed. 
This review primarily focuses on the regulatory role of hydrogen sulfide in controlling vascular tone. We 
attempt to provide recent insights into mechanisms by which CSE-dependent hydrogen sulfide plays a role 
in the regulation of vascular tone by perivascular adipose tissue. The role of KCNQ channels and other ionic 
permeation pathways as key targets will be discussed. Recent findings which are summarized in this paper 
provide new insights into molecular mechanisms of hydrogen sulfide that are crucial for understanding vas-
cular dysfunction in cardiovascular disease and possibly angiogenesis. Future research will be extended to 
investigate the therapeutic potential of hydrogen sulfide and their targets such as KCNQ channels in cardio-
vascular diseases, angiogenesis and tumor genesis. (Int J Biomedi Sci 2012; 8 (2): 81-86)
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INTRODUCTION
Hydrogen sulfide the “third” gasotransmitter
Hydrogen sulfide (H2S) is the “third” gasotransmitter 
next to nitric oxide (NO) and carbon monoxide (CO). A 
wide range of biological effects may be associated with 
H2S, including improved reperfusion in trauma and cir-
culatory shock (1), retardation of cardiac hypertrophy 
through its anti-fibrotic property (2), anti-hypertensive ef-
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fects through vasorelaxation (1) and suppression of vas-
cular inflammation (3). Furthermore, H2S regulates tumor 
angiogenesis via modulation of VEGF and activation of 
phosphatidylinositol-3-kinase (PI3K) and mitogen acti-
vated protein kinases (MAPK) (4).
H2S is endogenously produced by cystathionine-γ-
lyase (CSE) and cystathionine-ß-synthase (CBS) (1, 5). 
Other sources, particularly in red blood cells, have been 
identified (6), which suggest another H2S-generating en-
zyme, the 3-mercaptopyruvate-sulfurtransferase (3MST) 
(7, 8). H2S derived from CSE and CBS seems dependent 
upon pyridoxalphosphate (5) and the calcium calmodulin 
complex (9). Hypoxia may affect H2S production (10). In 
addition, tissue oxygen levels also regulate H2S-mediated 
actions (11). The different sources of H2S generation and 
biochemical pathways are presented in Figure 1 (modified 
from (7)).
Recent studies suggest a role for H2S in wound heal-
ing and angiogenesis. H2S promotes vessel formation via 
modulation of hypoxia inducible factor 1α (HIF-1α) and 
up-regulation of VEGF expression (12, 13). In addition, 
opening of K
ATP
 channels (14) and activation of phosphor-
ylation cascades might be also involved. H2S activates 
phosphatidylinositol-3-kinase (PI3K) and mitogen acti-
vated protein kinases (MAPK) in endothelial cells (4, 14). 
CSE inhibition reduces the pro-angiogenic effect of H2S 
(4). Some studies show that H2S exerts its proangiogenic 
effect in tumor cells. Exogenous H2S increases cytosolic 
calcium levels and activates potassium currents to stimu-
late migration (15). CSE inhibition can reduce tumor pro-
angiogenic signaling via decreasing VEGF (15).
DISCUSSION
Cystathionine-γ-lyase (CSE), H2S and ADRF
Soltis and Cassis showed that perivascular adipose tis-
sue attenuated the contractile response of rat aorta to nor-
epinephrine (16). Perivascular fat attenuated the contractile 
response of systemic arteries to serotonin, phenylephrine, 
angiotensin II, and other physiological relevant molecules 
(17, 18). Löhn et al. suggested that this anti-contractile ef-
fect is caused by an “adipocyte derived relaxing factor” 
(ADRF) which is yet to be identified (17). ADRF is a trans-
ferable factor that induces opening of voltage-dependent 
potassium (Kv) channels in vascular smooth muscle cells 
(VSMCs) and thus leads to cell membrane hyperpolarisa-
tion (17, 18). Glibenclamide partially inhibits ADRF effects 
in rat aortas by non-specific effects, which are distinct from 
inhibiting K
ATP
 channels (19). ADRF is independent of the 
presence of endothelium and NO-mediated mechanisms 
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Figure 1. Biochemical and metabolic pathways leading to the production of hydrogen sulfide. CSE, cystathionine-γ-lyase; CBS, cystathi-
onine-ß-synthase; CAT, cysteine-(aspartate)-aminotransferase; 3MST 3-mercaptopyruvate-sulfurtransferase. Figure modified from (8).
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(17). Leptin- and adenosine receptors do not participate in 
the anticontractile effect of perivascular fat (17). Inhibition 
of cyclooxygenase (COX) or cytochrome-P450-enzymes 
has no influence either (17). However, tyrosine kinases 
and PKA seem to be involved in the ADRF release (17, 
20). ADRF secretion is calcium-dependent. Sodium chan-
nels and vanilloid/canniboid receptors have no role in the 
ADRF effect, thus minimizing the possible involvement of 
perivascular nerve activity (20).
Several factors have been discussed as putative ADRFs. 
Renin-angiotensin system components such as angiotensin 
1-7 (21) and CSE-derived H2S are promising ADRF can-
didates (Figure 2). However, the nature of ADRF remains 
elusive. Perivascular fat exerts a vaso-protective effect in 
mouse and rat systemic peripheral arteries, while such 
protection appears to be lacking in hypertension and obe-
sity. New Zealand Obese (NZO) mice are commonly used 
in obesity research and their blood vessels are surrounded 
by increased amounts of perivascular fat. Interestingly, 
the vascular smooth muscle cells of very obese and dia-
betic NZO mice do not respond to paracrine modulation of 
perivascular fat via ADRF (22). Spontaneous hypertensive 
rats (SHR) show also diminished anticontractile effects of 
perivascular adipose tissue (23).
Recent data suggest that H2S plays an important role in 
tumor genesis and progression (24), which may in part be 
explained by inhibition of NF-kappaB and superoxide for-
mation (3, 24-26). However, the complex molecular path-
ways and interactions between obesity, hydrogen sulfide, 
and perivascular fat are still poorly understood.
Our group has recently investigated the interaction and 
potential target molecules of ADRF and H2S by focusing 
on 1) CSE-dependent H2S regulation of vascular tone and 
2) the possible role of KCNQ channels. Major results, to-
gether with recent studies on this topic, are presented in 
this paper.
Role of CSE and KCNQ channels in periadventitial 
vasorelaxation
Fang et al. and our group investigated the role of CSE-
dependent H2S in the anticontractile effect of perivascular 
fat in rat aortas (27, 28). Rat aortic rings without perivas-
cular fat exhibited a significantly stronger contraction in 
response to serotonin than rings with perivascular fat. CSE 
inhibition by PPG attenuated the anticontractile effect of 
perivascular fat (Figure 3) without affecting contractions 
in rings without perivascular fat (27, 28), suggesting that 
CSE-H2S may be involved in the anticontractile effects. 
Figure 2. Putative mechanisms involved in the regulation of arterial vascular tone by ADRF, H2S, and other adipokines. NO, nitric 
oxide. NOS, NO synthase. KCa, calcium-activated potassium channels. Kv, voltage-dependent potassium channels. KCNQ, KCNQ chan-
nels. Cl-/HCO
3
-, Cl-/HCO
3
-exchanger. CSE, cystathionine-γ-lyase; CBS, cystathionine-ß-synthase; 3MST, 3-mercaptopyruvate-sulfur-
transferase. SMC, vascular smooth muscle cell; EC, endothelial cell; Ang 1-7, angiotensin 1-7.
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Similar effects were seen with KCNQ channel inhibitor, 
XE991. XE991 attenuated the anticontractile effect of 
perivascular fat, suggesting that KCNQ channels mediate 
the ADRF effect, at least in part, in rat aortas (28). 
Relaxation of aortic rings by NaHS
H2S is a potent exogenous vasodilator. However, en-
dothelial cells has been proposed to serve as endogenous 
source of H2S. A number of pathways have been suggested 
to play a role in vasorelaxation by H2S, including formation 
of cyclic adenosine-mono-phosphate (cAMP) and subse-
quent action of protein kinase A (PKA) (29), endogenous 
prostanoids (30), activation of ATP-dependent potassium 
channels (K
ATP
) and of the Cl-/HCO
3
-
 transporter (11, 31, 
32). Figure 2 illustrates these important pathways. How-
ever, at low concentrations H2S promotes vasoconstriction 
via inhibition of the cAMP pathway (29) and possibly by 
binding NO, forming an inactive nitrosothiol (33). 
Our group tested the hypotheses that H2S can induce 
vasorelaxation by opening KCNQ channels in vascular 
smooth muscle cells (28). Serotonin precontracted rat 
aortic rings without perivascular fat were exposed to the 
H2S donor NaHS. One group of rings was preincubated 
with XE991 before precontraction with serotonin. The 
other groups of rings were preincubated with Kv inhibitor 
4-AP or XE991 or K
ATP
 channel blocker glibenclamide, 
respectively. NaHS induced a larger vasorelaxation in 
precontracted aortic rings with fat. This relaxation was 
blocked by XE991 (28) and attenuated by glibenclamide 
and 4-AP (data not shown). These results indicate that 
exogenous H2S can induce stronger relaxation in rat aor-
tas and this relaxation involves opening of KCNQ chan-
nels and/or cooperative opening of both KCNQ and K
ATP
 
channels.
Complex interaction between ADRF and H2s
The studies of Fang et al. and our studies provide novel 
insights into the complex interaction between ADRF and 
H2S (27, 28). First, H2S modulates vascular tone of rat aortas 
in a perivascular fat-dependent manner. CSE inhibition at-
tenuates the anticontractile effect of perivascular fat in these 
arteries. Furthermore, exogenous H2S induces vasorelax-
ation which can be blocked by KCNQ channel inhibition. 
Glibenclamide is also effective, indicating involvement of 
K
ATP
 or non-specific effects as observed earlier by our group 
in this preparation (19). Thus, H2S might act as a putative 
ADRF targeting KCNQ channels, at least, in rat aortas. 
Second, CSE-derived H2S is unlikely a direct ADRF 
candidate in mouse aortas as it is observed that CSE inhi-
bition with PPG does not affect the anticontractile effects 
of perivascular fat (unpublished data). CBS is another en-
zyme catalyzing the formation of H2S. Many publications 
describe CSE and CBS as the main enzymes catalyzing the 
endogenous H2S production from l-cysteine (1). However, 
its effect in the regulation of vascular tone by perivascu-
lar fat is largely unclear. Future studies should determine 
whether inhibition of CBS is able to reduce the ADRF ef-
fect in mouse aortas. Further studies are also needed to in-
vestigate whether exogenous l-cysteine, the main precursor 
of endogenously produced H2S, is able to induce relaxation 
in mouse aortas and whether the effects can be blocked by 
CSE inhibition. Furthermore, a possible role of 3MST needs 
to be investigated to understand the complex interaction of 
endogenously produced H2S and perivascular fat (Figure 1).
Activation of KCNQ channels by H2S (ADRF) 
Based on pharmacological data with XE991, an inhibi-
tor of KCNQ channels, our group was able to identify a 
specific role of KCNQ channels in inducing relaxation by 
perivascular adipose tissue and exogenous NaHS (H2S) in 
rat aortas. Thus, opening of KCNQ channels seems to be a 
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Figure 3. Serotonin (5-HT) dose response curve of rat aortic 
rings with and without perivascular fat with and without prein-
cubation with PPG (30 min, 10 mmol/l). *p<0.05, n=9 in groups 
without preincubation. n=8 for groups with PPG. Isometric con-
tractions of isolated male adult rat aortic vessels. Perivascular 
fat and connective tissue were either removed ((-) fat) or left 
intact ((+) fat) as previously described by Löhn et al. (17, 18, 
20, 38). PPG had no effects on (-) fat rings (not shown). Tension 
is expressed as a percentage of the steady state tension (100%) 
obtained with isotonic external 60 mmol/l KCl (28). A value of 
p less than 0.05 was considered statistically significant; n repre-
sents the number of arteries tested.
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key mechanism in vasorelaxation induced by both ADRF 
and H2S. The results suggest that KCNQ channel opening 
might also serve as a powerful mechanism to induce va-
sorelaxation in ADRF malfunctioning such as in obesity 
and hypertension. Future research needs to focus on this 
hypothesis.
CSE-derived H2S has been recently proposed as 
ADRF in rat aortas (27, 28). In line, Fang et al. showed 
CSE expression in vascular smooth muscle cells and 
periadventitial adipocytes but not in the endothelium 
of rat aortas (27). In contrast, Yang et al. detected CSE 
expression in endothelium but not in VSMCs in mouse 
aortas (9). In line with the latter results, we observed that 
CSE inhibition by PPG does not modify the relaxation 
by perivascular adipose tissue in mouse aortas. Taking 
together, CSE-derived H2S seems to be rather an ADRF 
modulator than a direct ADRF in mouse aortas (Figure 
2). However, PPG had to be used at suspicious high con-
centrations in order to block CSE. More detailed studies 
using different CSE inhibitors, other donors than NaHS, 
and CSE deficient mice are essential to underpin the role 
of CSE in endothelial and periadventitial vasoregulation 
of arterial tone.
Exogenous H2S donors and novel therapeutic strategies
As mentioned earlier, a number of studies reported 
strong vasorelaxation of systemic arteries by NaHS. How-
ever, the results with NaHS are difficult to interpret be-
cause of the unknown kinetics of H2S release by NaHS. 
ADTOH is a novel, promising H2S donor. ADTOH is a di-
thiole-3-thione moiety of H2S-releasing aspirin and there-
fore not only liberates H2S but also suppresses the throm-
boxane A2 activity (34). It will be important to test whether 
ADTOH mimics ADRF in vitro and in vivo. These studies 
will clarify the role of exogenous H2S in the ADRF effects 
and the complex interaction between inflammation, H2S 
and perivascular fat in vascular dysfunction of obesity-
related hypertension. 
Previous studies identified elevation of various pro-
inflammatory cytokines secreted by perivascular adipose 
tissue in states of ischemia and hypoxia whereas protective 
effects of adiponectin and other adipokines were reduced. 
Involved molecules are components of the renin-angioten-
sin system, interleukin 1 (IL-1), IL-6, tumor necrosis fac-
tor α (TNF α), and C-reactive protein (35, 36). Additional 
production of reactive oxygen species increases oxidative 
stress which triggers vascular inflammation, associated 
with hypertension (37), and may promote cancer develop-
ment (24). Kotsis et al. showed that malfunctioning adi-
pose tissue in obesity not only stimulates the release of 
pro-inflammatory molecules but also that of thromboxane 
A2 (35). Therefore, studies using ADTOH might not only 
provide information about H2S as an ADRF modulator but 
also present a novel putative link between its vasodilatory 
and anti-inflammatory actions in states of ADRF malfunc-
tion. ADTOH and other H2S donors may provide novel 
therapeutic strategies to target ADRF malfunction. There-
fore, this research is expected to identify novel, promising 
pharmaceutical strategies to treat vascular dysfunction in 
cardiovascular diseases.
CONCLUSIONS AND PERSPECTIVES
Investigation of the paracrine role of adipose tissue in 
regulating vascular tone and function is an exciting and 
rapidly advancing area of medical research which provides 
many new and emerging pathophysiological links to car-
diovascular diseases. Recent research is focused on the 
complex interaction between perivascular adipose tissue 
and H2S as novel regulators of vascular tone and modu-
lators of vascular inflammation. However, future studies 
and genetic approaches are required to clarify the role of 
CSE in the vasculature. Recent research has identified 
KCNQ channel opening as a powerful mechanism to in-
duce vasorelaxation by the mode of H2S-mediated regula-
tion. However, this conclusion is mainly based on the use 
of the pharmacological blocker XE991 in rat and mouse 
aortas. Therefore, additional studies are required to de-
termine the role of these channels in other vascular beds. 
Furthermore, we tend to believe that ADTOH could be a 
promising novel molecule to attenuate the progression of 
vascular dysfunction. 
This manuscript describes vascular effects of H2S and 
perivascular adipose tissue and presents some new in-
sights into putative pharmaceutical targets for the treat-
ment of obesity-related hypertension. However, similar 
mechanisms of local vascular inflammation and hypoxia 
also play a crucial role in vessel formation, tumor develop-
ment and growth so that these studies shall also provide a 
basis for further research in angiogenesis and cancer with 
a hope of finding new therapeutic strategies.
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